Article Link: https://www.insideprecisionmedicine.com/topics/precision-medicine/the-end-of-the-beginning-for-cell-and-gene-therapy-part-2/
Part 2: How T Cell Activation Redefines TIL and CAR-T Manufacturing (Boosting Success Rates to 95%) with Chantale Bernatchez
When every batch belongs to a single patient, a single centralized facility cannot serve the world. In Part 2, Chantale Bernatchez moves from...